Digital therapeutics are evidence-based, clinically evaluated software and devices that can be used to treat an array of diseases and disorders, accordingto the Digital Therapeutics Alliance, the industry's trade association. They can be used independently or with medications, devices, and other ...
Digital pills are designed to augment traditional therapies. But some in the medical community believe that tech can someday replace pills altogether — a category sometimes referred to as "digital therapeutics." Digital therapeutics goes beyond sensor-laden pills to include other digital elements, lik...
2.Patient-centric solutions should be scalable across several conditions.Solutions must meet patients where they are in their health journey and offer a holistic interpretation of health. At this day in age (and at this point in the epidemiological transition) most individuals with chronic diseases ...
Among the wide realm of health digital technologies, the rise of Digital Therapeutics (DTx), which are medical devices able to deliver evidence-based treatments to manage and treat diseases, opens new opportunities. However, their diffusion and usage are still fragmented among countries. As the ...
These examples are just a sampling of what people can expect this year as more pharmaceutical company leaders explore how AI could help their processes. Creating new drugs is often a significant gamble with numerous unknown factors. Artificial intelligence could remove or reduce many of them, leadin...
The emergence of AI has generated much for even those embedded in the technological field. An approach to machine learning and artificial control intelligence should probably stem from an understanding of what it is and what it can do. In taking this approach, we are positioning ourselves in a...
ConcertAI was built to create greater contributions to societal, economic, and environmental benefits over time. For two examples: first, we are a digital company operating in multiple geographies with a distributed workforce. Our operating models meld software-as-a-service (SaaS) tools...
The biotech industry is starting to see real progress with AI-focused drug discovery companies reaching meaningful milestones or readouts of clinical trials –Relay TherapeuticsandRecursionare two examples. These successful readouts are catalyzing more investment into the space. Big pharma has done $20B...
healthcare consumers are looking for new models, and digital therapeutics offers an intriguing method to manage chronic conditions. In fact, Kaiser Permanentereported that 50 percentof provider visits were virtual, and behavioral health is seeing even more rapid utilization. Insurers and providers should...
Related Reading18 3D Printing Applications and ExamplesDisadvantages of BioprintingMaterial IncompatibilityGiven the fact that the technology and hardware used in bioprinting are simply adaptations from basic 3D-printing systems designed for plastics and metals, this aspect of development faces severe ...